Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema

PaperCitations, authors & open-access status

Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 78 citations, 2021 year and bronze oa status.

78
Citations
2021
Year
bronze
OA Status

Related on ScholarIQ

Sara Touhami
Author
Ophthalmology
Journal
Ocular Diseases and Behçet’s Syndrome
Topic
Ocular Diseases and Behçet’s Syndrome
Topic
Sarcoidosis and Beryllium Toxicity Research
Topic
Retinal Diseases and Treatments
Topic
470M+ articles · free account